Skip to Main Content
Diseases of the Cardiovascular System

The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

What is the purpose of this trial?

A prospective, non blinded, single arm, multicenter study designed to assess the safety and effectiveness of the bioprosthetic, VenoValve, which is surgically implanted into the deep venous system for treatment of patients with deep venous valvular insufficiency ( C4b-C6 patients).

The purpose of this study is to evaluate the VenoValve System (Hancock Jaffe Laboratories) in human patients. The VenoValve System is designed for treatment of chronic deep venous insufficiency. The VenoValve System enables improvement in chronic lower extremity venous reflux through an open surgical technique. The objective of this study is to assess the safety and effectiveness of the VenoValve System for the treatment of patients with deep venous valvular insufficiency and the associated complications.

Watch this video of Drs. Chaar, Aboian, and Guzman, discuss this cutting edge technology for the treatment of Chronic Venous Insufficiency. Yale is one of the leading sites in the US for this study.

  • Trial with
    enVVeno Medical Corporation (Formerly known as Hancock Jaffe Laboratories)
  • Ages
    18 years and older
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Caelan Watts

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    04/03/2024
  • Study HIC
    #2000030794